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Abstract
Sarcoptic mange is a globally distributed disease caused by the burrowing mite Sarcoptes scabiei, which also causes
scabies in humans. A wide and increasing number of wild mammal species are reported to be susceptible to
mange; however, the impacts of the disease in wildlife populations, mechanisms involved in its eco-epidemiological
dynamics, and risks to public and ecosystem health are still unclear. Major gaps exist concerning S. scabiei host
specificity and the mechanisms involved in the different presentations of the disease, which change between
individuals and species. Immunological responses to the mite may have a relevant role explaining these different
susceptibilities, as these affect the clinical signs, and consequently, the severity of the disease. Recently, some
studies have suggested sarcoptic mange as an emerging threat for wildlife, based on several outbreaks with
increased severity, geographical expansions, and novel wild hosts affected. Disease ecology experts convened for
the “International Meeting on Sarcoptic Mange in Wildlife” on 4–5 June 2018, hosted by the Department of Fish
and Wildlife Conservation at Virginia Tech in Blacksburg, Virginia, USA. The meeting had a structure of (i) pre-
workshop review; (ii) presentation and discussions; and (iii) identification of priority research questions to
understand sarcoptic mange in wildlife. The workgroup concluded that research priorities should be on
determining the variation in modes of transmission for S. scabiei in wildlife, factors associated with the variation of
disease severity among species, and long-terms effects of the mange in wildlife populations. In this note we
summarize the main discussions and research gaps identified by the experts.
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Background
Sarcoptic mange is a common, highly contagious skin
disease of mammals caused by the burrowing mite Sar-
coptes scabiei [1]. Clinical signs of sarcoptic mange are
characterized by hair loss, epidermal crusts, and pruritic
dermatitis, and may be present as an acute or chronic
process. Impacts in hosts vary widely among mammal
species by factors including mite lineage and host im-
munity [1, 2]. Sarcoptic mange is still being reported in
new geographical areas, new animal species, and with new
clinical presentations. Empirical evidence demonstrates
sarcoptic mange as an emerging wildlife disease in some
instances, potentially representing a threat to some wild
populations, and an established endemic disease in many
other cases [3, 4]. However, the potential long-term ef-
fects of mange in wildlife and the causes of the devel-
opment of epidemic and endemic patterns are still
poorly understood [5].
Overview of the meeting
Due to the increasing reports of sarcoptic mange affect-
ing wildlife around the globe (Fig. 1), a group of re-
searchers met during June 4–5, to discuss the current
global situation regarding sarcoptic mange in wildlife
populations. This report summarizes the main discus-
sions and conclusions raised during the meeting entitled
* Correspondence: escobar1@vt.edu
1Department of Fish and Wildlife Conservation, Virginia Tech, Blacksburg, VA,
USA
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Astorga et al. Parasites & Vectors  (2018) 11:449 
https://doi.org/10.1186/s13071-018-3015-1
“International Meeting on Sarcoptic Mange in Wildlife”,
organized and hosted by the Department of Fish and
Wildlife Conservation at the Virginia Polytechnic Insti-
tute and State University (Virginia Tech) and supported
by funding from the Global Change Center (N° 177219).
A total of 13 participants presented different aspects
of sarcoptic mange, information on state-of-the-art re-
search and outbreaks management. Participants repre-
sented academic, federal, state, and non-government
institutions from four continents, providing a wide
spectrum of approaches to the problem. The main ob-
jectives of the meeting were to (i) generate a scoping
study of recent advances in the understanding of mange
in wildlife, which included discussions regarding new
host species, novel geographical areas affected, factors
associated with mange outbreaks, and effects of mange
in the affected wildlife populations, among others; and
(ii) identify major information gaps, which included gen-
eration of research questions to be addressed with iden-
tification of their priority and feasibility. To accomplish
these objectives, the meeting was divided into twelve
sessions, preceded by two months of online discussions
before the meeting. The first day of the meeting con-
sisted of logistic instructions, plenary discussions, and
the development of a scoping study [6] to map the
current lines of research in mange. The second day we
discussed knowledge gaps and future research topics
(Fig. 2). The presentations were sub-structured by geo-
graphical region and research area.
Session 1: Negative effects of parasites on wildlife
(Moderator: Dr Paul Cross)
Mange is a contagious disease with characteristic and ob-
vious clinical signs. Sarcoptic mange has negatively af-
fected wildlife globally, specifically grey wolves (Canis
lupus lupus), red foxes (Vulpes vulpes) and coyotes (Canis
latrans) in the USA, and red foxes in Europe. Current
studies and experimental data show that negative effects
may be observable at the population level (e.g. reduction
in population densities, removal of juveniles), or at the in-
dividual level, such as increased heat loss. These individual
impacts may produce behavioral shifts towards decreased
movements, increased activities during warmer parts of
the day, and increased food consumption, among others.
Mange in wildlife species has a general epidemiological
pattern, characterized by an initial epizootic phase (with
higher prevalence and mortality), followed by an endemic
cycle of lower prevalence and potential fade-out. The in-
tensity and impact of the disease appears to vary dramatic-
ally among different host species.
Fig. 1 Different wildlife species affected by mange. a Roe deer (Capreolus capreolus) severely affected by mange (e.g. see hair loss in head, neck,
and thorax) in Europe. b Giraffe (Giraffa reticulata) found affected by mange in Africa (inset: a close up to the animal’s mouth affected by mange).
c Bare-nosed wombat (Vombatus ursinus) infected by mange in Tasmania; note the crusted lesions in the face and shoulder. d Cheetah (Acynonyx
jubatus) found infected with mange in Africa; note the loss of hair in the abdomen
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Research gaps identified
 What are the drivers that result in fade out or low
endemicity of mange?
 How do immunological, ecological, behavioral and
population differences change how mange impact
animals across a host species?
 What are the prognostic factors for severe mange
infestation at the individual, group and population
level?
 What is the relationship between mange infestation
and co-infestations/infections with other parasites?
Session 2: Sarcoptic mange in western North
America (Moderator: Dr Emily Almberg)
Reports of sarcoptic mange in peer-reviewed and gray
literature demonstrate that the mite is widely distributed
across North America, with most infections reported in
the canid family (i.e. wolves, coyotes and foxes), but also
among American black bears (Ursus americanus), rac-
coons (Procyon lotor), porcupines (Erethizon dorsatum),
white-tailed deer (Odocoileus virginianus) and wild
boar (Sus scrofa) (Fig. 3). Studies report both endemic
and epidemic conditions, with common observations of
outbreak severity peaking during winter and spring
months and with high host densities. In North America,
there are few reports of mange in far northern latitudes
and in extremely arid environments, potentially reflect-
ing a lack of historic disease invasion or low susceptible
host densities. Aside from these general observations, lit-
tle is known regarding the biogeographical patterns of
the disease, including paths of spread, mite lineages, and
environmental drivers of epidemics. In the case of west-
ern North America, geographical barriers such as Rocky
Mountains may impose an element to be considered as
a limiting feature. However, no research has been con-
ducted to understand the current spatial distribution of
mange across the North American continent.
One of the earliest written reports of sarcoptic mange
in North America dates to 1909, when the veterinarian
for the state of Montana in the United States
intentionally infected up to 200 wolves and coyotes with
sarcoptic mange and released them to assist with
Fig. 2 Workshop framework. The first component of the workshop included discussions regarding the state of knowledge of mange in wildlife,
followed by a group session to define new research lines
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predator control efforts [7]. More recently, sarcoptic
mange has been closely studied in the Yellowstone Na-
tional Park, Wyoming, where S. scabiei invaded the rein-
troduced wolf population in 2007 [8–10]. From these
studies, we have found that wolves infected with S. sca-
biei may undergo behavioral changes to cope with the
costs of infection, including decreased movement, selec-
tion of warmer habitats, increased food consumption, as
well as increased social reliance on fellow pack mem-
bers. Research has also explored the potential predictors
of sarcoptic mange severity and associated mortality.
Current studies show no associations between individual
risk and severity of wolf mange infestations with pack
size, age, sex, coat color. Previous infections do not ap-
pear to protect individuals from re-infection. Short-term
population declines were noted during the initial out-
break of mange, but long-term impacts on population
size and resiliency remain an understudied area.
Research gaps identified
 What drives variation in mange infestation among
equally exposed individuals?
 What factors drive the seasonality of mange severity
seen in wolf infestations?
 What is the prevalence and impact of mange in
areas where there has been no focused reporting or
research efforts?
 Does host adaptation affect patterns of mange
infestation seen in sympatric host species?
 When should we consider disease management or
intervention for mange?
 What are the drivers of mange outbreaks in wildlife?
 Are epidemics driven by new infections in novel/
uninfested hosts, or are they the result of changes in
host and environmental factors?
 Are there any gaps in mange distribution in wildlife
across North America, and if so, what is the reason
for non-mange endemic areas?
Session 3: Sarcoptic mange in eastern North
American wildlife (Moderator: Dr Kevin D.
Niedringhaus)
Wildlife species in eastern North America, such as the
red fox, gray fox (Urocyon cinereoargenteus), coyote,
white-tailed deer, American black bear, gray squirrel
(Sciurus carolinensis), fox squirrel (Sciurus niger) and
the North American porcupine are all affected with
mange. Some species are infested specifically with S. sca-
biei, while others are affected by other mites from the
genera Notoedres, Demodex, Chorioptes, Psoroptes or
Otodectes. Although major efforts exist in sampling
white-tailed deer, there are only a few positive cases in
this species, revealing the asymmetrical susceptibility
among hosts. Sarcoptic mange is emerging in many spe-
cies globally, and in North America, mange is becoming
more common in the American black bear. Only a few
studies have been published in this emerging system.
There are new tools to improve diagnoses; however,
multiple skin scrapes are still considered the most sensi-
tive test for mite identification and disease diagnosis
[11]. Unlike mange in many other species, the highest
concentrations of mange in bears are not centered around
urban or suburban areas [12]. Lastly, the emergence of
mange in bears may not be a result of a new, genetically
distinct, or highly virulent mite species based on limited
gene targets [13]. Additional research regarding mange in
Fig. 3 Coarse overview of the areas and species reported infected with mange in the northern North America. The map shows patterns of
mange distribution from scientific (black) and gray literature (blue). Silhouettes represent species where mange has been reported
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black bears is needed to understand the sudden emer-
gence of the disease in this previously-considered unusual
host.
Research gaps identified
 Is there a role for indirect transmission of mites
between bears via carcasses or other fomites?
 How can field serology be utilized to determine
mange exposure in black bear populations?
 Are bears only transmitting mites between
themselves or are other sympatric species involved?
 Why are there fewer reports of sarcoptic mange in
cervids, bovids, mustelids and felids in North
America compared to other continents?
Session 4: Mange (Sarna) in Latin America
(Moderator: Dr Francisca Astorga)
While mange is common in dogs and livestock in Latin
America and has been described in at least 24 wildlife
species in this region, data on the disease are very
scarce, resulting in unknown impacts on wild popula-
tions. Since it occurs so often in dogs, it is currently not
widely reported, and is not considered a notifiable dis-
ease [14]. Camelids are one group with more frequent
reports concerning mange, as it causes economic losses
to small farmers (e.g. damage of leather, loss of wool,
mortality) [15, 16] and may represent an emerging threat
to wild native camelids (e.g. Lama glama guanicoe) [17].
There is a growing concern about mange transmission
between wildlife and livestock, with questions centered
on which species is the source of infestation. Mange has
also been suggested as the most important disease in the
native rodent capybara (Hydrochaeris hydrochaeris) in
captivity and in free-ranging populations [18]. Addition-
ally, it is noted that most wild canids in Latin America
are solitary animals, or tend to live in small families,
which is different from North America where canids
occur in larger packs. However, a few outbreaks in native
canids have been reported [19–21]. The source of these
outbreaks is unknown, with potential transmission from
domestic dogs or from infected prey [21]. In general,
there is a lack of information concerning sarcoptic
mange, and grey literature such as theses or institutional
reports may be considered as a relevant complementary
resource, e.g. [22].
Research gaps identified
 What is the most effective and feasible way to
obtain more data and implement monitoring
solutions to determine how mange is impacting
wildlife?
 How does disease transmission in canids from North
America differ from disease transmission in Latin
American canids (social vs solitary/small family?)
 Is mange in Latin America primarily originating
from wildlife and being transmitted to livestock and
other domestic animals, or vice versa?
 What role do dogs play in the transmission of
mange to other dogs, domestic livestock and wildlife
in Latin America?
 Is there an intraguild transmission, a prey-predator
transmission, or a combination of the two transmis-
sion pathways?
Session 5: Sarcoptic mange in Europe (Moderator:
Dr Christian Gortázar)
Mange in Europe is recorded in several species, and is
widespread in European carnivores, wild ruminants, wild
boar and lagomorphs. However, mange only has increased
relevance in carnivores with regards to red fox and Arctic
fox (Alopex lagopus). Mange seems to have an endemic
cycle in most local hosts, particularly in the Iberian Penin-
sula, being a part of the natural cycles of the communities.
In the long term, wildlife populations in Europe seem to
be able to recover and remain stable in number. This pat-
tern suggests that mange control in wildlife in Europe
should only be implemented in exceptional situations. A
relevant topic is the host-specificity of the mite: in Europe,
mange mites seem to affect ungulates much more as com-
pared with North America ungulates (Fig. 1). In North
America, ungulates seem to be unaffected or unexposed.
Previous studies in Europe have suggested a
taxon-specificity (ungulate- and carnivore- cluster) [23];
however, studies have not been conducted in the
Americas.
Research gaps identified
 What are the dynamics involved in the shift from
epidemic to endemic cycle of sarcoptic mange in
wildlife populations?
 How do factors such as co-infections, health condi-
tion, and genetics influence mange infestation in
wildlife?
 How can mortality due to mange be properly
assessed and differentiated from other causes of
death?
 Is sarcoptic mange a threat for biodiversity
conservation? Which species or populations should
be considered for intervention?
Session 6: Mange in Oceania (Moderator: Dr Scott
Carver)
In Oceania, Australia is the only country in which sar-
coptic mange seems to be a real issue in wildlife (there
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are only two chiropteran native terrestrial mammals in
New Zealand, and mange reports were rare to
non-existent elsewhere in Oceania). Mange has been re-
ported in many native species in Australia (e.g. koalas,
Phascolarctos cinereus; dingoes, Canis lupus dingo) but
is known for having the greatest impacts on wombats [5,
24]. Of the three extant wombat species, the bare-nosed
wombat (Vombatus ursinus, a.k.a. common wombat) is
the most impacted, experiencing widespread endemic
disease, with sporadic disease outbreaks and localized
population declines [25] (Fig. 1). The southern
hairy-nosed wombat (Lasiorhinus latifrons) is also im-
pacted [26], but to a lesser extent, and S. scabiei may
represent a major threat to the northern hairy-nosed
wombat (L. krefftii), which is critically endangered. In
order to assess and develop wombat conservation strat-
egies, recent efforts have focused on individual and
population impacts of mange in wombats [25], mange
control mechanisms, molecular epidemiology of the mite
[27, 28] and a comparison of diagnostic methods [29].
Individual impacts of mange in wombats include aber-
rant behavior, inefficient thermoregulation and environ-
mental heat loss, and increased metabolism, all of which
contribute to changes in wombat foraging and resting
patterns [25, 30]. During disease outbreaks, recent re-
search has shown wombat population densities to be in-
versely related to mange prevalence [25]. There have
also been recent experiments evaluating in-field
population-scale mange control using topical cydectin
treatment of wombats, with the results in preparation
for publication. Investigations into the molecular epi-
demiology of S. scabiei have revealed close genetic asso-
ciation between mites derived from wombats, koalas and
humans [27]. Recent work has greatly expanded the S.
scabiei genetic material from Australia and shows mul-
tiple circulating haplotypes in mammals across the con-
tinent (and globally) implicating multiple S. scabiei
invasion events to Australia, originating with European
settlers to the continent [31].
Research gaps identified
 What are the best treatment options and delivery
strategies that would result in control, and
ultimately, significant reduction of mange in
wombats?
 How do the environmental conditions affect mange
transmission?
 What factors shape the range of animal hosts
affected by the S. scabiei mite?
 Are there differences in immune gene expression
between healthy wombats and those infested with
mange, and if so, how is immune gene expression
associated with severity of disease within skin and
tissues?
Session 7: Sarcoptic mange in Asia (Moderator: Dr
Yue Xie)
Sarcoptic mange has been reported throughout Asia in
both wildlife and captive species. While cases have been
reported in Japan, China, Korea and Israel, the number
of wildlife cases has been deemed limited, with out-
breaks occurring in specific geographical locations. Ru-
minants are noted as being the most prominent wildlife
species infested with S. scabiei. Infested ruminants in-
clude mountain gazelles (Gazella gazella), Nubian ibex
(Capra nubiana), barbary sheep (Ammotragus lervia),
elands (Taurotragus oryx), Arabian oryx (Oryx leu-
coryx), Alpine ibex (Capra ibex), blue sheep (Pseudois
nayaur), tufted deer (Elaphodus cephalophus), gorals
(Naemorhedus goral) and serows (Capricornsis suma-
traensis). Outbreaks of sarcoptic mange in raccoon dogs
(Nyctereutes procyonoides) have been reported since
1993. Mange infestation in captive wildlife species such
as red panda (Ailurus fulgens), sika deer (Cervus nippon),
Chinese mountain cats (Felis bieti) and rhesus monkeys
(Macaca mulatta) have also been reported in China.
Research gaps identified
 Why are cases of mange in wildlife in Asia deemed
to be few in number compared to other continents?
 Is the limited number of outbreaks due to limited
reporting or surveillance data for wildlife?
 Are there any endangered species currently
impacted that require intervention efforts?
 What is the relationship between mange in domestic
species and mange cases in wildlife and/or captive
wildlife species?
Session 8: Sarcoptes scabiei in humans: a public
health perspective (Moderator: Kimberly
Wingfield)
Domestic animals, wildlife, and humans can all be
infested with the S. scabiei mite, which is termed mange
in animals or scabies in humans. Human scabies occurs
when individuals are infested with the human mite (S.
scabiei var. hominis), and zoonotic scabies occurs when
infested with an animal host-specific variant of the mite
[32]. Human scabies is more readily transmissible be-
tween humans and is generally more clinically severe for
humans as compared to zoonotic scabies [33–35]. Thus,
treatment is required for human scabies, whereas zoo-
notic scabies is generally transient and self-limiting [35,
36]. In all cases of scabies, risk of secondary infection is
increased due to disruption of the skin’s protective layer
[36]. For both human scabies and zoonotic scabies,
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clearing of the mite from the environment is key in pre-
venting further transmission of the disease [35, 37].
Those with occupational hazards for S. scabiei mite in-
festation (i.e. human health care workers or animal care
professionals) should take extra precautions such as
donning protective clothing to prevent mite infestation.
Additionally, in cases of zoonotic scabies, treatment of
the animal for mange is a necessary step to prevent the
continued spread of mites to humans and to other
animals.
Research gaps identified
 How can proper diagnosis and determination of
mite origin be improved in order to differentiate
scabies from other dermatological diseases, and/or
differentiate classic human scabies from zoonotic
scabies?
 Is it possible for a human with zoonotic scabies to
further transmit the mite(s) to other humans or
back to another animal?
 What explains the variability in disease severity
among people infected with S. scabiei?
 What methodologies can be developed and
implemented in order to increase monitoring and
reporting of zoonotic scabies?
 What percentage of scabies cases are zoonotic in
origin?
 Which S. scabiei lineages infest humans more
frequently?
Session 9: Treatment of mange in wildlife
(Moderator: Dr Peach Van Wick)
Treatment for mange in wildlife is similar to that for do-
mestic animal species (e.g. routes and options of treat-
ment); however, the feasibility of treating wildlife poses
certain challenges. For example, a common treatment
option for mange in wildlife is the administration of two
doses of ivermectin, approximately two weeks apart. Al-
though effective, this option necessitates the animal(s)
be held in a captive environment or re-captured in the
field to receive the full treatment. Another consideration
in managing mange in wildlife is deciding if treatment
should be conducted at the individual or population
level or if treatment should be pursued at all. Addition-
ally, the available treatment options for mange (i.e. aver-
mectins, milbemycins and isoxazolines) were developed
for the use in domestic animals or humans, not for wild-
life. Thus, treatment options and protocols are often ex-
trapolated from domestic species assuming effectiveness
in wildlife. Additional concerns such as drug residues in
edible tissues must be considered if the wildlife is hunted
for human consumption.
Research gaps identified
 What is the feasibility of treating wildlife, and is it
necessary?
 Should treatment of mange be targeted only for
isolated or endangered populations, or should it be
targeted for those populations with highest
infestation risk that could potentially spread mange
to other species?
 Should treatment of secondary issues of mange (e.g.
bacterial skin infections, emaciation) also be of
treatment focus in wildlife?
 Is vaccination an appropriate and more proactive
treatment option?
 What procedures can be implemented to ensure
decreased consumption risk of mange treatment
residues in wildlife that are considered as game?
 What considerations should be developed and
implemented to address environmental
contamination from mange treatment in wildlife?
Session 10: Immunology of mange in wildlife
(Moderator: Dr Giovane R. Sousa)
The immune response to S. scabiei in wildlife is poorly
understood. However, a consistent pattern is that an ini-
tial mange infection leads to suppression of the immune
system possibly through mite secreted substances [38].
These mite antigens might cause an anti-inflammatory
immune response and this inhibitory mechanism seems
to help mites to survive in the host skin and establish a
population during the early stages of the disease. Then,
there is a shift to allergic and inflammatory responses
and symptoms of the disease are manifested [39]. Previ-
ous studies have shown that the response to mange dif-
fers among distinct host species. For instance, dogs,
humans and rabbits acquire full immunity. Conversely,
red foxes do not seem to have immune response to
mange due to lack of memory T-cells after initial infec-
tion. Additionally, the immune response can be uneven
within the same species due to the sex of the animal, or
previous exposure status. Mange in American black
bears has become an emerging concern and thus the hy-
pothesis that mite-mediated immune response is associ-
ated with the pathogenesis of mange in free-ranging
black bears has been investigated. In preliminary data,
inflammatory genes NF-kB, IFN-γ and TNF-α appear to
be upregulated in mange-infested black bears compared
to healthy black bears not infested with mange. Interest-
ingly, a wide variation could be observed within the S.
scabiei-infested group for its expression of NF-kB and
IFN-γ, important genes for activation of the inflamma-
tory response. It is possible that those animals with in-
creased activation of these genes may well be those who
presented a more severe progression toward disease
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involvement. With regards to genes IL-10 and IL-4,
which regulates the expression of those
anti-inflammatory cytokines, no significant difference in
expression between healthy black bears and those
infested with mange have been observed. Taken together,
these results suggest that parasite-mediated immune re-
sponse in free-ranging black bears is characterized by a
predominantly inflammatory immune response, which
might associate with mange severity.
Research gaps identified
 How can the effect of immunological responses on
mange severity be studied in wildlife?
 What host-parasite interaction factors are the pri-
mary drivers for both positive and negative clinical
outcomes of mange in wildlife?
Session 11: Phylogenetics of wildlife mange
(Moderators: Drs Samer Angelone & Luca Rossi)
Sarcoptic mange is a very old disease, first described for
humans in the 11th century. There are two important
events in the history of scabies infestation discovery in
humans: in the early 11th century it was proposed that
the clinical symptoms of mange were caused by a para-
site [40]; and in the 17th century occurred the identifica-
tion of Sarcoptes by Francesco Redi Arezzo [41]. A more
recent discovery is host-taxon derived Sarcoptes, as
grouped by herbivore, carnivore and omnivore hosts
[42]. Transmission mechanisms between animal hosts,
and the role that fomites play have been studied, but
more research to elucidate these mechanisms is needed
[43]. Several studies have been developed recently con-
cerning the epidemiology and genetics of sarcoptic
mange in wildlife [44]. In Europe, a taxon-associated
cluster was found, i.e. transmission seems to be mainly
among species from the same taxonomic group (herbi-
vores vs carnivores) [42]. In contrast, in the Masai Mara
Reserve (Africa), transmission seems to be occurring be-
tween prey and predators (Fig. 1) [45]. In the meantime,
in order to obtain more data, scientific communities
should consider Citizen Science, to invite tourists and
the local community to report potential cases of mange
in wildlife [46]. Additionally, data integration groups
such as those of the Sarcoptes-World Molecular Net-
work, may help to provide more information on S. sca-
biei transmission via information exchange efforts and
building of databases for research analyses [47].
Research gaps identified
 How can phylogenetic data be used understand
sarcoptic mange transmission?
 How does S. scabiei move between and among
different host species?
 How can problems in research such as
unstandardized epidemiological methodology, small
sample sizes of research papers on the topic, and
lack of outgroups be overcome when studying
mange?
 How effective are mange detector dogs and PCR in
diagnosis mange in wildlife? Are these solutions
feasible?
Table 1 Main questions (and sub-elements) concerning wildlife
mange
Question
(i) What are the transmission dynamics of S. scabiei in wildlife?
Temporal dynamics (epidemic, endemic, contemporary and historical)
Significance for species conservation
Pandemic or globally endemic
Species dynamics (single or multi-species)
Wildlife-domestic animals-human interface
Ecosystem level consequences
(ii) What is the biogeographical history of S. scabiei?
Native range / origins
Pathways of spread: unintentional (e.g. trade, colonization) and
intentional (e.g. host population control)
Ecological (e.g. host distribution), climatic (e.g. temperature, humidity)
and geographic barriers (e.g. oceans, mountains)
(iii) What is the variation in modes of transmission for S. scabiei in
wildlife?
Intra-specific interactions (spatial and temporal variation)
Inter-specific interactions (trophic, sympatry)
Environmental effects
Mite lineages / strains
(iv) What is the feasibility and anticipated effectiveness of intervention
strategies in wildlife?
Methodological (individual level, population level, environmental)
Economic
Indirect impacts
(v) When should intervention strategies for mange be considered in
wildlife?
Conservation concerns
Ethical/welfare concerns
Public health and domestic animal (agricultural and companion)
concerns
Ecological role of the parasite in nature (e.g. natural selection)
(vi) What shapes the variation of disease severity at intra-specific and
inter-specific levels?
The role of co-infections
Variation in immune response (e.g. immunological pathways
influencing disease progression or control, ordinary vs crusted mange)
Environmental factors
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Session 12: Research questions and future
directions (Moderator: Dr Luis E. Escobar)
The final session included a participatory determination
of mange in wildlife research needs. During the second
day, participants independently wrote up to ten key
questions, which all participants then grouped into clus-
ters based on similarities. These clusters were then sum-
marized, organized, and discussed in order to classify
the final list of questions, with sub-components, in
terms of their relevance to the understanding of mange
in wildlife (Table 1).
Conclusions
Wildlife diseases play a major role in biodiversity conser-
vation [48, 49]. However, effects of most diseases in
wildlife species remain poorly understood. Sarcoptic
mange is a worldwide distributed disease, which affects
mammal species, populations and individuals. Although
it is an old disease, there remains much to be learned of
its ecology and epidemiology in wildlife. To develop a
comprehensive global assessment of mange and the
threats it poses to wildlife, further efforts are recom-
mended to concentrate in questions that addresses the
major gaps identified here (Table 1). We propose six
major research questions that, if explored, will augment
our understanding of the natural history of mange in
wildlife. Finally, mange is an ideal disease to implement
One Health research because it can affect domestic and
wildlife animals and humans and the habitat can play a
role in the transmission. Mange is also an excellent sys-
tem to better understand host-parasite interactions and
the biogeography of ectoparasites.
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